Latest News about CMPS
Recent news which mentions CMPS
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
From Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
From Benzinga
Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS' Published Results
November 18, 2022
Tickers
CMPS
From Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
From Benzinga
Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes
November 16, 2022
Tickers
CMPS
From Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
From Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
From Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
From Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
From Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
From Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance
November 07, 2022
From Benzinga
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
November 04, 2022
Tickers
CMPS
From Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
From Benzinga
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
CMPS
From Motley Fool
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
November 03, 2022
From Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
From Benzinga
Why Shares of atai Life Sciences Climbed 14.58% on Tuesday
November 01, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities
October 31, 2022
From Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
October 28, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
From Benzinga
20-year-old investor who made $110 million on a meme stock is pushing for change at a psychedelics company
October 26, 2022
From MarketWatch
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
From Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
October 21, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 18, 2022
October 18, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.